Serglycin proteoglycan in hematologic malignancies: A marker of acute myeloid leukemia

Leukemia

Volumn 21, Issue 12, 2007, Pages 2406-2410

  Niemann, C U ^a   Kjeldsen, L ^a   Ralfkiaer, E ^a   Jensen, M K ^a   Borregaard, N ^a  

^a Rigshospitalet   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; MYELOPEROXIDASE; PROTEOGLYCAN; SERGLYCIN; UNCLASSIFIED DRUG;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; HEMATOLOGIC MALIGNANCY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LARGE CELL LYMPHOMA; MYELOBLAST; MYELOPROLIFERATIVE DISORDER; PHILADELPHIA CHROMOSOME NEGATIVE CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION;

EID: 36348981009     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/sj.leu.2404975     Document Type: Article

References (26)

1. Kolset SO, Gallagher JT. Proteoglycans in haemopoietic cells. Biochim Biophys Acta 1990; 1032: 191-211.
2. Kolset SO, Prydz K, Pejler G. Intracellular proteoglycans. Biochem J 2004; 379 (Part 2): 217-227.
3. Niemann CU, Abrink M, Pejler G, Fischer RL, Christensen EI, Knight SD et al. Neutrophil elastase depends on serglycin proteoglycan for localization in granules. Blood 2007; 109: 4478-4486.
4. Stevens RL, Avraham S, Gartner MC, Bruns GA, Austen KF, Weis JH. Isolation and characterization of a cDNA that encodes the peptide core of the secretory granule proteoglycan of human promyelocytic leukemia HL-60 cells. J Biol Chem 1988; 263: 7287-7291.
5. Maillet P, Alliel PM, Mitjavila MT, Perin JP, Jolles P, Bonnet F. Expression of the serglycin gene in human leukemic cell lines. Leukemia 1992; 6: 1143-1147.
6. Stellrecht CM, Mars WM, Miwa H, Beran M, Saunders GF. Expression pattern of a hematopoietic proteoglycan core protein gene during human hematopoiesis. Differentiation 1991; 48: 127-135.
7. Cowland JB, Borregaard N. The individual regulation of granule protein mRNA levels during neutrophil maturation explains the heterogeneity of neutrophil granules. J Leukoc Biol 1999; 66: 989-995.
8. Schick BP, Gradowski JF, San Antonio JD. Synthesis, secretion, and subcellular localization of serglycin proteoglycan in human endothelial cells. Blood 2001; 97: 449-458.
9. Niemann CU, Cowland JB, Klausen P, Askaa J, Calafat J, Borregaard N. Localization of serglycin in human neutrophil granulocytes and their precursors. J Leukoc Biol 2004; 76: 406-415.
10. Toyama-Sorimachi N, Kitamura F, Habuchi H, Tobita Y, Kimata K, Miyasaka M. Widespread expression of chondroitin sulfate-type serglycins with CD44 binding ability in hematopoietic cells. J Biol Chem 1997; 272: 26714-26719.
11. Humphries DE, Wong GW, Friend DS, Gurish MF, Qiu WT, Huang C et al. Heparin is essential for the storage of specific granule proteases in mast cells. Nature 1999; 400: 769-772.
12. Forsberg E, Pejler G, Ringvall M, Lunderius C, Tomasini-Johansson B, Kusche-Gullberg M et al. Abnormal mast cells in mice deficient in a heparin-synthesizing enzyme. Nature 1999; 400: 773-776.
13. Abrink M, Grujic M, Pejler G. Serglycin is essential for maturation of mast cell secretory granule. J Biol Chem 2004; 279: 40897-40905.
14. Raja SM, Wang B, Dantuluri M, Desai UR, Demeler B, Spiegel K et al. Cytotoxic cell granule-mediated apoptosis. Characterization of the macromolecular complex of granzyme B with serglycin. J Biol Chem 2002; 277: 49523-49530.
15. Grujic M, Braga T, Lukinius A, Eloranta ML, Knight SD, Pejler G et al. Serglycin-deficient cytotoxic T-lymphocytes display defective secretory granule maturation and granzyme B storage. J Biol Chem 2005; 280: 33411-33418.
16. Kjeldsen L, Bainton DF, Sengelov H, Borregaard N. Identification of neutrophil gelatinase-associated lipocalin as a novel matrix protein of specific granules in human neutrophils. Blood 1994; 83: 799-807.
17. Lollike K, Kjeldsen L, Sengelov H, Borregaard N. Purification of lysozyme from human neutrophils, and development of an ELISA for quantification in cells and plasma. Leukemia 1995; 9: 206-209.
18. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR et al. Proposals for the classification of the acute leukaemias. French-American-British (FAB) co-operative group. Br J Haematol 1976; 33: 451-458.
19. Lollike K, Kjeldsen L, Sengelov H, Borregaard N. Lysozyme in human neutrophils and plasma. A parameter of myelopoietic activity. Leukemia 1995; 9: 159-164.
20. Faurschou M, Borregaard N. Neutrophil granules and secretory vesicles in inflammation. Microbes Infect 2003; 5: 1317-1327.
21. Jaffe ES, Krenacs L, Raffeld M. Classification of cytotoxic T-cell and natural killer cell lymphomas. Semin Hematol 2003; 40: 175-184.
22. Baxter EJ, Scott LM, Campbell PJ, East C, Fourouclas N, Swanton S et al. Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders. Lancet 2005; 365: 1054-1061.
23. Stevens RL, Otsu K, Austen KF. Purification and analysis of the core protein of the protease-resistant intracellular chondroitin sulfate E proteoglycan from the interleukin 3-dependent mouse mast cell. J Bioi Chem 1985; 260: 14194-14200.
24. Stevens RL, Humphries DE, Wong GW. Serglycin proteoglycans: The family of proteoglycans stored in the secretory granules of certain effector cells of the immune system. In: Iozzo RV (ed). Proteoglycans Structure, Biology, and Molecular Interactions. Marcel Dekker Inc.: New York, NY, 2000, pp 177-200.
25. Nicodemus CF, Avraham S, Austen KF, Purdy S, Jablonski J, Stevens RL. Characterization of the human gene that encodes the peptide core of secretory granule proteoglycans in promyelocytic leukemia HL-60 cells and analysis of the translated product. J Biol Chem 1990; 265 5889-5896.
26. Lohmander LS, Arnljots K, Yanagishita M. Structure and synthesis of intracellular proteoglycan in HL-60 human leukemic promyelocytes. J Biol Chem 1990; 265: 5802-5808.